SC 13D

SCHEDULE 13D

Company: NovaBridge Biosciences
Filed: December 1, 2023
Accession Number: 0000943663-23-000195

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →

View Document ↗ View on SEC.gov ↗